Disruptive Technology Channel ARK Completes Move to Florida With Broad Research Team By Todd RosenbluthNovember 22, 2022
Disruptive Technology Channel ARK Partners With BMO to Bring ARK Funds to Canada By Nick Peters-GoldenNovember 18, 2022
Disruptive Technology Channel Biotech Earnings, Market Leap Boost ARKG Potential By Nick Peters-GoldenNovember 11, 2022
Disruptive Technology Channel As Flu Season Consumers Prefer Telehealth, Watch ARKG By Nick Peters-GoldenNovember 2, 2022
Disruptive Technology Channel ARKG Holding PacBio’s 1-Month Returns Top 48% By Elle CarusoOctober 24, 2022
Disruptive Technology Channel Senti Biosciences Increases 22% Thursday as Markets Rally By Elle CarusoOctober 13, 2022
Disruptive Technology Channel ARKK Takes in Nearly Half Billion in September Flows By Elle CarusoOctober 5, 2022
Disruptive Technology Channel Positive Sentiment in Biotech Intensifies, Add ARKG By Elle CarusoSeptember 21, 2022
Disruptive Technology Channel ARK Changes Management on Passive ETF Lineup By Elle CarusoSeptember 19, 2022
Expert Insights VettaFi ETF Research and Data Is Being Recognized By Todd RosenbluthSeptember 19, 2022
Disruptive Technology Channel ARKG Offers Exposure to Advancements in Synthetic Biology By Elle CarusoSeptember 15, 2022
Disruptive Technology Channel Shares of Signify Health Propelled by Buyout Prospects By Elle CarusoSeptember 1, 2022
Disruptive Technology Channel Opportunities Emerge From Rapid Cost Declines in Gene Editing and Synthesis By Elle CarusoAugust 26, 2022
Disruptive Technology Channel ARKG Holding Butterfly Network Increases 127% in Past Month By Elle CarusoAugust 12, 2022
Disruptive Technology Channel ARKG Top Holding Signify Reported to Be Acquisition Target by CVS By Elle CarusoAugust 8, 2022
Disruptive Technology Channel Investors Flocked to ARKK and ARKG in July as Growth Rebounded By Elle CarusoAugust 5, 2022
Disruptive Technology Channel Shares of Verve Therapeutics Up 84% in Past Month; Get Exposure With ARKG By Elle CarusoJuly 26, 2022
